Inventor · disambiguated record
George J. Mulligan
Also filed as: MULLIGAN GEORGE · MULLIGAN GEORGE J
7 granted patents·10 pending applications·25 citations·filing 2003–2022
80Inventor score
Top patents by PatentIndex Score
17 records- 0187US9963747B2Methods for the identification, assessment, and treatment of patients with cancer therapyMILLENNIUM PHARM INC·Filed 2014·Granted May 8, 2018·7 cites·19 claims
- 0286US8278038B2Methods for the identification, assessment, and treatment of patients with cancer therapyBRYANT BARBARA M·Filed 2006·Granted Oct 2, 2012·10 cites·14 claims
- 0385US8889354B2Methods for the identification, assessment, and treatment of patients with cancer therapyBRYANT BARBARA M·Filed 2012·Granted Nov 18, 2014·5 cites·11 claims
- 0474US9827246B2Biomarkers of response to NAE inhibitorsMILLENNIUM PHARM INC·Filed 2012·Granted Nov 28, 2017·3 cites·33 claims
- 0556US2009181393A1Methods for the identification, assessment, and treatment of patients with proteasome inhibition therapyMILLENNIUM PHARM INC·Filed 2008·Application pending·0 cites
- 0656US2024358681A1Methods of use of ppar agonist compounds and pharmaceutical compositions thereofMITOBRIDGE INC·Filed 2022·Application pending·0 cites
- 0754US2010086922A1Assessment of chromosomal alterations to predict clinical outcome of bortezomib treatmentMILLENNIUM PHARM INC·Filed 2009·Application pending·0 cites
- 0851US10953013B2Biomarkers of response to NAE inhibitorsMILLENNIUM PHARM INC·Filed 2016·Granted Mar 23, 2021·0 cites·12 claims
- 0950US2016312309A1Assessment of chromosomal alterations to predict clinical outcome of bortezomib treatmentMILLENNIUM PHARM INC·Filed 2016·Application pending·0 cites
- 1049US2018117069A1Methods of treatment of cancerMILLENNIUM PHARM INC·Filed 2017·Application pending·0 cites
- 1149US2016008382A1Methods of treatment of cancerMILLENNIUM PHARM INC·Filed 2013·Application pending·0 cites
- 1247US2004156854A1Methods for the identification, assessment, and treatment of patients with proteasome inhibition therapyMILLENNIUM PHARM INC·Filed 2003·Application pending·0 cites
- 1347US2017157155A1Method of treatment of nasopharyngeal cancerMILLENNIUM PHARM INC·Filed 2016·Application pending·0 cites
- 1444US9500656B2Methods for the identification, assessment, and treatment of patients with cancer therapyBRYANT BARBARA M·Filed 2007·Granted Nov 22, 2016·0 cites·21 claims
- 1543US2017023577A1Methods for the identification, assessment, and treatment of patients with proteasome inhibition therapyMILLENNIUM PHARM INC·Filed 2016·Application pending·0 cites
- 1641US11268154B2Methods for the identification, evaluation and treatment of patients having multiple myelomaMILLENNIUM PHARM INC·Filed 2016·Granted Mar 8, 2022·0 cites·19 claims
- 1731US2015184246A1Biomarkers of response to proteasome inhibitorsMILLENNIUM PHARM INC·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when George J. Mulligan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →